Viveve Medical, Inc. (VIVE) |
|
0.0599 -0 (-0.17%)
|
03-17 15:37 |
|
Open: |
0.06 |
Pre. Close: |
0.06 |
|
High:
|
0.0638 |
Low:
|
0.051 |
|
Volume:
|
43,898 |
Market Cap:
|
1(M) |
|
|
|
Technical analysis |
as of: 2023-03-20 7:50:43 AM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 0.09 One year: 0.11 |
| Support: |
Support1: 0.05 Support2: 0.04 |
| Resistance: |
Resistance1: 0.08 Resistance2: 0.1 |
| Pivot: |
0.06 |
| Moving Average: |
MA(5): 0.05 MA(20): 0.07
MA(100): 0.32 MA(250): 0.6 |
| MACD: |
MACD(12,26): -0.1  Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 18.5 %D(3): 11 |
| RSI: |
RSI(14): 32 |
| 52-week: |
High: 1.24 Low: 0.05 |
| Average Vol(K): |
3-Month: 345 (K) 10-Days: 32 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ VIVE ] has closed above bottom band by 29.5%. Bollinger Bands are 90% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 27 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.06 - 0.06 |
0.06 - 0.06 |
|
Low:
|
0.05 - 0.05 |
0.05 - 0.05 |
|
Close:
|
0.06 - 0.06 |
0.06 - 0.06 |
|
Company Description |
|
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado. |
Headline News |
Wed, 18 Jan 2023
VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.com
Tue, 17 Jan 2023
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Se - Benzinga
Tue, 17 Jan 2023
Why Is Tritium (DCFC) Stock Up 27% Today? - InvestorPlace
Tue, 17 Jan 2023
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and ... - InvestorPlace
Tue, 17 Jan 2023
U.S. stocks mixed at close of trade; Dow Jones Industrial Average ... - Investing.com
Tue, 17 Jan 2023
Viveve Medical (VIVE) Reports PURSUIT Trial Did Not Meet ... - StreetInsider.com
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
11 (M) |
| Shares Float |
11 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
4.7 (%) |
|
Shares Short
|
374 (K) |
|
Shares Short P.Month
|
178 (K) |
Stock Financials |
|
EPS
|
-2.66 |
|
EPS Est Next Qtl
|
-0.42 |
|
EPS Est This Year
|
-1.95 |
|
EPS Est Next Year
|
-1.39 |
|
Book Value (p.s.)
|
0.1 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-309.8 |
|
Return on Assets (ttm)
|
-62.2 |
|
Return on Equity (ttm)
|
-211 |
|
Qtrly Rev. Growth
|
4.1 |
|
Gross Profit (p.s.)
|
0.05 |
|
Sales Per Share
|
0.63 |
|
EBITDA (p.s.)
|
-1.9 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-16 (M) |
|
Levered Free Cash Flow
|
-8 (M) |
Stock Valuations |
|
PE Ratio
|
-0.03 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.54 |
|
Price to Sales
|
0.09 |
|
Price to Cash Flow
|
-0.04 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2020-12-01 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
